Ascendis aims to raise $300M; Basilea inks up to $268M deal with BARDA

Plus, news about GSK, Novo Nordisk, Tanai Therapeutics, Nomic Bio, Brenus Pharma, Xspray, Achilles Therapeutics, BioXcel Therapeutics and Nuvalent:

Ascendis’ $300M offering: The Danish company …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Covid-19 vaccine granted EUA by China

The vaccine demonstrated an excellent safety profile and 93.28% protective efficacy 14 days after injection. Credit: WestVac BioPharma Co., Ltd./ CNW. WestVac Biopharma has announced

June 9, 2023

Kodiak ends attempt at an Eylea rival as its biologic fails two of three PhIII trials

Kodiak Sciences’ attempt at making an Eylea rival for patients with various eye conditions has come to an end. The California biotech is scrapping its

July 25, 2023

Psychedelic Conference Marks a Shift in the Strategy of the Psychedelic Industry | Psychedelic Invest

I arrived in Miami last Wednesday, ready for a few days of bright colors, passionate conversations, and mind-manifesting ideas. Psychedelic Week was in full swing,

November 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.